Published in JAMA · View the paper (DOI)
A study published in JAMA found that policies restricting pharmaceutical detailing associated with modest but significant reductions in prescribing of detailed drugs across six major drug classes. The implementation of these policies led to a shift away from detailed drugs and towards generic drugs, potentially representing a large red...
Coverage from 2 institutions